621 Real World Study

NCT05646004 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 105

Last updated 2026-06-25

Study results available
· View outcomes & findings →

Summary

This study is evaluating the clinical safety and effectiveness of 621, after cataract surgery.

Conditions

  • Senile Cataract

Interventions

DEVICE

Cataract surgery

Implantation of 621 lens

Sponsors & Collaborators

  • Carl Zeiss Meditec AG

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-09
Primary Completion
2023-11-27
Completion
2023-11-27

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05646004 on ClinicalTrials.gov